Literature DB >> 17712315

mGluR7 facilitates extinction of aversive memories and controls amygdala plasticity.

M Fendt1, S Schmid, D R Thakker, L H Jacobson, R Yamamoto, K Mitsukawa, R Maier, F Natt, D Hüsken, P H Kelly, K H McAllister, D Hoyer, H van der Putten, J F Cryan, P J Flor.   

Abstract

Formation and extinction of aversive memories in the mammalian brain are insufficiently understood at the cellular and molecular levels. Using the novel metabotropic glutamate receptor 7 (mGluR7) agonist AMN082, we demonstrate that mGluR7 activation facilitates the extinction of aversive memories in two different amygdala-dependent tasks. Conversely, mGluR7 knockdown using short interfering RNA attenuated the extinction of learned aversion. mGluR7 activation also blocked the acquisition of Pavlovian fear learning and its electrophysiological correlate long-term potentiation in the amygdala. The finding that mGluR7 critically regulates extinction, in addition to acquisition of aversive memories, demonstrates that this receptor may be relevant for the manifestation and treatment of anxiety disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17712315     DOI: 10.1038/sj.mp.4002073

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  49 in total

1.  Viral-mediated knockdown of mGluR7 in the nucleus accumbens mediates excessive alcohol drinking and increased ethanol-elicited conditioned place preference in rats.

Authors:  Amine Bahi
Journal:  Neuropsychopharmacology       Date:  2012-07-11       Impact factor: 7.853

2.  Functional monoclonal antibody acts as a biased agonist by inducing internalization of metabotropic glutamate receptor 7.

Authors:  C Ullmer; S Zoffmann; B Bohrmann; H Matile; L Lindemann; Pj Flor; P Malherbe
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

Review 3.  Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear.

Authors:  Hans-Christian Pape; Denis Pare
Journal:  Physiol Rev       Date:  2010-04       Impact factor: 37.312

4.  Regulation of N-methyl-D-aspartic acid (NMDA) receptors by metabotropic glutamate receptor 7.

Authors:  Zhenglin Gu; Wenhua Liu; Jing Wei; Zhen Yan
Journal:  J Biol Chem       Date:  2012-01-27       Impact factor: 5.157

5.  Activation of the mGlu7 receptor elicits antidepressant-like effects in mice.

Authors:  Agnieszka Palucha; Kinga Klak; Piotr Branski; Herman van der Putten; Peter J Flor; Andrzej Pilc
Journal:  Psychopharmacology (Berl)       Date:  2007-07-12       Impact factor: 4.530

6.  mGluR2/3 in the Lateral Amygdala is Required for Fear Extinction: Cortical Input Synapses onto the Lateral Amygdala as a Target Site of the mGluR2/3 Action.

Authors:  Jihye Kim; Bobae An; Jeongyeon Kim; Sewon Park; Sungmo Park; Ingie Hong; Sukwon Lee; Kyungjoon Park; Sukwoo Choi
Journal:  Neuropsychopharmacology       Date:  2015-05-25       Impact factor: 7.853

7.  Fear-reducing effects of intra-amygdala neuropeptide Y infusion in animal models of conditioned fear: an NPY Y1 receptor independent effect.

Authors:  Markus Fendt; Hugo Bürki; Stefan Imobersteg; Kurt Lingenhöhl; Kevin H McAllister; David Orain; Doncho P Uzunov; Frederique Chaperon
Journal:  Psychopharmacology (Berl)       Date:  2009-07-17       Impact factor: 4.530

8.  The metabotropic glutamate receptor 7 (mGluR7) allosteric agonist AMN082 modulates nucleus accumbens GABA and glutamate, but not dopamine, in rats.

Authors:  Xia Li; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Neuropharmacology       Date:  2007-11-19       Impact factor: 5.250

9.  Click-modified cyclodextrins as nonviral vectors for neuronal siRNA delivery.

Authors:  A M O'Mahony; B M D C Godinho; J Ogier; M Devocelle; R Darcy; J F Cryan; C M O'Driscoll
Journal:  ACS Chem Neurosci       Date:  2012-08-03       Impact factor: 4.418

10.  Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes.

Authors:  J Elia; X Gai; H M Xie; J C Perin; E Geiger; J T Glessner; M D'arcy; R deBerardinis; E Frackelton; C Kim; F Lantieri; B M Muganga; L Wang; T Takeda; E F Rappaport; S F A Grant; W Berrettini; M Devoto; T H Shaikh; H Hakonarson; P S White
Journal:  Mol Psychiatry       Date:  2009-06-23       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.